News > News Archive

MRI Interventions' ClearPoint System Enables Precise Delivery of Promising Investigational Gene Therapy in Parkinson's Disease Phase I Clinical Trial

Researchers at University of California, San Francisco and National Institutes of Health have begun a Phase I clinical study utilizing MRI Intervention’s ClearPoint System to enable direct infusion of a gene therapy, glial cell line-derived neurotrophic factor (GDNF), into an area of the brain affected by Parkinson’s disease. Read more…

Go to earlier archived stories